Published in Gastroenterology on March 01, 1992
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10
Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut (1995) 2.29
High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med (2012) 1.44
Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenomas and carcinomas. Clin Exp Immunol (1998) 1.15
Expression of cell membrane complement regulatory glycoproteins along the normal and diseased human gastrointestinal tract. Gut (1998) 0.96
PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage. Mol Med (2010) 0.94
Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis. Gut (1997) 0.90
The intestinal B-cell response in celiac disease. Front Immunol (2012) 0.84
Avidity progression of dietary antibodies in healthy and coeliac children. Clin Exp Immunol (2003) 0.79
Specific nongluten proteins of wheat are novel target antigens in celiac disease humoral response. J Proteome Res (2014) 0.79
Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells. Clin Exp Immunol (2007) 0.78
Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies. Dig Dis Sci (2010) 0.78
Extracts of wheat gluten activate complement via the alternative pathway. Clin Exp Immunol (1993) 0.78
Serum mannan-binding lectin levels in patients with celiac disease: an analysis of clinical and autoimmune features. Dig Dis Sci (2007) 0.77
Prostaglandin E2 and Krüppel-like transcription factors synergistically induce the expression of decay-accelerating factor in intestinal epithelial cells. Immunology (2008) 0.77
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med (1989) 6.99
Guidelines for human gene nomenclature (1997). HUGO Nomenclature Committee. Genomics (1997) 6.44
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med (1998) 5.25
Conjugates of immunoglobulin G with different fluorochromes. I. Characterization by anionic-exchange chromatography. Scand J Immunol (1973) 4.81
The immune geography of IgA induction and function. Mucosal Immunol (2008) 4.06
TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem (1997) 3.81
Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev (2000) 3.69
Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol (2001) 3.55
Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique. Immunology (1974) 3.47
Immunohistochemical characterization of local immunoglobulin formation in ulcerative colitis. Gastroenterology (1974) 3.13
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med (1993) 3.10
SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol Microbiol (1997) 3.01
Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology (1989) 2.98
Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet (1990) 2.73
Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology (1998) 2.69
Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med (1989) 2.68
Overview of the mucosal immune system. Curr Top Microbiol Immunol (1989) 2.64
HLA-DR-like antigens in the epithelium of the human small intestine. Scand J Immunol (1980) 2.58
Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon. Clin Exp Immunol (1975) 2.40
Duodenal adenomatosis in familial adenomatous polyposis. Gut (2004) 2.38
Mucosal and glandular distribution of immunoglobulin components: differential localization of free and bound SC in secretory epithelial cells. J Immunol (1974) 2.33
Intraepithelial T cells of the TcR gamma/delta+ CD8- and V delta 1/J delta 1+ phenotypes are increased in coeliac disease. Scand J Immunol (1989) 2.29
Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut (1995) 2.29
Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J Exp Med (1999) 2.24
Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol (1986) 2.20
Health related quality of life in patients with spina bifida: a prospective assessment before and after lower urinary tract reconstruction. J Urol (2009) 2.20
The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med (2001) 2.19
Immunoglobulin M: local synthesis and selective secretion in patients with immunoglobulin A deficiency. Science (1968) 2.19
Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol (1988) 2.17
Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins. Nature (1984) 2.16
Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci (2003) 2.07
Parents' and GPs' key role in diagnosis of meningococcal septicaemia. Lancet (2000) 2.04
Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol (1997) 1.98
Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy. J Immunol (2000) 1.97
Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: immunohistochemical evidence. Gastroenterology (1989) 1.93
Immunohistochemical studies of the formation and epithelial transport of immunoglobulins in normal and diseased human intestinal mucosa. Scand J Gastroenterol Suppl (1976) 1.92
Transport models for secretory IgA and secretory IgM. Clin Exp Immunol (1981) 1.90
Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut (1994) 1.87
Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol (1987) 1.85
Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol (1996) 1.84
Quantitative determination of bile acids and their conjugates using thin-layer chromatography and a purified 3alpha-hydroxysteroid dehydrogenase. Scand J Gastroenterol (1974) 1.78
Role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man. Scand J Immunol (1985) 1.76
Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology (1987) 1.76
Outcome of very severe birth asphyxia. Arch Dis Child (1976) 1.75
Some arguments on early hospital admission and treatment of suspected meningococcal disease cases. NIPH Ann (1990) 1.73
Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol (1987) 1.73
Adsorption of immunolgobulin A onto oral bacteria in vivo. J Bacteriol (1968) 1.68
Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin Exp Immunol (1981) 1.66
Presence of J chain in human immunocytes containing various immunoglobulin classes. Nature (1974) 1.66
Two types of IgA immunocytes in man. Nat New Biol (1973) 1.65
Retardation of immunofluorescence fading during microscopy. J Histochem Cytochem (1985) 1.64
Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology (1997) 1.62
Immunoglobulin systems of human tonsils. I. Control subjects of various ages: quantification of Ig-producing cells, tonsillar morphometry and serum Ig concentrations. Clin Exp Immunol (1978) 1.61
Familial opsonization defect associated with fatal infantile dermatitis, infections, and histiocytosis. Arch Dis Child (1975) 1.61
Human secretory immunoglobulins. II. Salivary secretions from individuals with selectively excessive or defective synthesis of serum immunoglobulins. Clin Exp Immunol (1971) 1.58
Germline and somatic mutations in exon 15 of the APC gene and K-ras mutations in duodenal adenomas in patients with familial adenomatous polyposis. Scand J Gastroenterol (1999) 1.58
Lymphoepithelial interactions in the mucosal immune system. Gut (1988) 1.58
Self-induced correction of the genetic defect in tyrosinemia type I. J Clin Invest (1994) 1.57
Polymerase chain reaction for case ascertainment of meningococcal meningitis: application to the cerebrospinal fluids collected in the course of the Norwegian meningococcal serogroup B protection trial. Scand J Infect Dis (1996) 1.55
Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J Exp Med (1998) 1.55
The human secretory immune system shows striking heterogeneity with regard to involvement of J chain-positive IgD immunocytes. J Immunol (1979) 1.55
Use of fresh-frozen plasma at Royal Darwin Hospital: a retrospective audit. Intern Med J (2008) 1.54
Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology (1990) 1.53
Specific and nonspecific humoral defense factors in the epithelium of normal and inflamed gastric mucosa. Immunohistochemical localization of immunoglobulins, secretory component, lysozyme, and lactoferrin. Gastroenterology (1984) 1.53
Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol (1985) 1.53
HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol (1982) 1.53
T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol (1994) 1.52
Cranberry juice for the prevention of pediatric urinary tract infection: a randomized controlled trial. J Urol (2012) 1.51
Human secretory immunoglobulins. I. Salivary secretions from individuals with normal or low levels of serum immunoglobulins. Scand J Haematol Suppl (1970) 1.51
Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis. Gut (1993) 1.50
Serum bile acid concentrations in patients with liver disease. Scand J Gastroenterol (1976) 1.49
Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines. Scand J Immunol (1992) 1.47
In vivo and in vitro binding of IgA to the plasma membrane of hepatocytes. Scand J Immunol (1978) 1.47
Polymeric IgA is complexed with secretory component (SC) on the surface of human intestinal epithelial cells. Scand J Immunol (1978) 1.46
CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. Gastroenterology (1998) 1.45
The human gastrointestinal secretory immune system in health and disease. Scand J Gastroenterol Suppl (1985) 1.44
Tumor necrosis factor-alpha up-regulates expression of secretory component, the epithelial receptor for polymeric Ig. J Immunol (1988) 1.43
Human secretory component--VI. Immunoglobulin-binding properities. Immunochemistry (1977) 1.43
Mucosal penetration of antigen in the presence or absence of serum-derived antibody. Immunology (1977) 1.42
Studies on J chain and binding site for secretory component in circulating human B cells. Clin Exp Immunol (1976) 1.42
Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation. Scand J Gastroenterol (2002) 1.40
The nursing profession must be more assertive over pay. Br J Nurs (2002) 1.40
Activated T lymphocytes in the celiac lesion: non-proliferative activation (CD25) of CD4+ alpha/beta cells in the lamina propria but proliferation (Ki-67) of alpha/beta and gamma/delta cells in the epithelium. Eur J Immunol (1993) 1.40
Up-regulation of the expression of secretory component and HLA molecules in a human colonic cell line by tumour necrosis factor-alpha and gamma interferon. Scand J Immunol (1988) 1.40